RU2359680C2 - Применение комплексных соединений железа (iii) - Google Patents
Применение комплексных соединений железа (iii) Download PDFInfo
- Publication number
- RU2359680C2 RU2359680C2 RU2007133509/15A RU2007133509A RU2359680C2 RU 2359680 C2 RU2359680 C2 RU 2359680C2 RU 2007133509/15 A RU2007133509/15 A RU 2007133509/15A RU 2007133509 A RU2007133509 A RU 2007133509A RU 2359680 C2 RU2359680 C2 RU 2359680C2
- Authority
- RU
- Russia
- Prior art keywords
- iron
- iii
- use according
- maltodextrins
- deficiency
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100907.4 | 2005-02-09 | ||
| EP05100907 | 2005-02-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2007133509A RU2007133509A (ru) | 2009-03-20 |
| RU2359680C2 true RU2359680C2 (ru) | 2009-06-27 |
Family
ID=34938674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007133509/15A RU2359680C2 (ru) | 2005-02-09 | 2006-01-18 | Применение комплексных соединений железа (iii) |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US8722101B2 (ja) |
| EP (1) | EP1848446B1 (ja) |
| JP (1) | JP5060312B2 (ja) |
| KR (1) | KR20070107106A (ja) |
| CN (1) | CN101155593A (ja) |
| AT (1) | ATE445406T1 (ja) |
| AU (1) | AU2006212322B2 (ja) |
| BR (1) | BRPI0606974A2 (ja) |
| CA (1) | CA2597154C (ja) |
| CR (1) | CR9300A (ja) |
| CY (1) | CY1109685T1 (ja) |
| DE (1) | DE502006005100D1 (ja) |
| DK (1) | DK1848446T3 (ja) |
| ES (1) | ES2333814T3 (ja) |
| HR (1) | HRP20100027T1 (ja) |
| IL (1) | IL185020A (ja) |
| MX (1) | MX2007009588A (ja) |
| NO (1) | NO20074536L (ja) |
| PL (1) | PL1848446T3 (ja) |
| PT (1) | PT1848446E (ja) |
| RU (1) | RU2359680C2 (ja) |
| SI (1) | SI1848446T1 (ja) |
| TN (1) | TNSN07307A1 (ja) |
| UA (1) | UA88347C2 (ja) |
| WO (1) | WO2006084782A1 (ja) |
| ZA (1) | ZA200707716B (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| CA2953964A1 (en) | 2006-01-06 | 2007-07-19 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron |
| EP2165713B1 (en) * | 2008-09-19 | 2012-11-14 | Nestec S.A. | Whey and thymus function |
| SI2411053T1 (sl) * | 2009-03-25 | 2017-04-26 | Pharmacosmos Holding A/S | Stabilna spojina železovega oligosaharida |
| WO2012104204A1 (en) | 2011-01-31 | 2012-08-09 | Vifor (International) Ag | Iron-carbohydrate complex compounds for the intravenous therapy of malaria |
| US11395502B2 (en) * | 2012-10-18 | 2022-07-26 | Patrick Monsivais | Formulation for iron supplements |
| RU2015146368A (ru) * | 2013-03-28 | 2017-05-04 | Вифор (Интернациональ) Аг | КОМПЛЕКСНЫЕ СОЕДИНЕНИЯ Fe(III) ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ СИМПТОМОВ ЖЕЛЕЗОДЕФИЦИТНОЙ АНЕМИИ И СИДЕРОПЕНИЧЕСКОЙ АНЕМИИ |
| KR20150078375A (ko) * | 2013-12-30 | 2015-07-08 | 한화케미칼 주식회사 | 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물 |
| FR3075001B1 (fr) * | 2017-12-14 | 2021-09-10 | Tereos Starch & Sweeteners Belgium | Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau |
| CN114288320A (zh) * | 2021-12-29 | 2022-04-08 | 珠海天翼医药技术开发有限公司 | 一种猪用口服补铁剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3076798A (en) * | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
| US3766165A (en) * | 1966-08-17 | 1973-10-16 | Pfizer | Polysaccharides and their preparation |
| DE4421159C1 (de) | 1994-06-20 | 1995-08-24 | Thomas Bruns | Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche |
| DE19734293A1 (de) * | 1997-08-08 | 1999-02-11 | Boehringer Mannheim Gmbh | Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen |
| EP1363951B1 (en) | 2000-12-07 | 2006-10-25 | AD "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrzivanje I Razvoj | Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
| EP1377594A4 (en) * | 2001-04-10 | 2004-06-30 | Danisco Usa Inc | POLYMERIZATION OF MONO AND DISACCHARIDES WITH MONOCARBOXYLIC ACIDS AND LACTONS |
| ATE335008T1 (de) | 2002-04-09 | 2006-08-15 | Pharmacosmos Holding As | Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel |
| DE10249552A1 (de) * | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
-
2006
- 2006-01-18 JP JP2007554530A patent/JP5060312B2/ja not_active Expired - Fee Related
- 2006-01-18 SI SI200630432T patent/SI1848446T1/sl unknown
- 2006-01-18 UA UAA200708978A patent/UA88347C2/ru unknown
- 2006-01-18 PT PT06707742T patent/PT1848446E/pt unknown
- 2006-01-18 PL PL06707742T patent/PL1848446T3/pl unknown
- 2006-01-18 AT AT06707742T patent/ATE445406T1/de active
- 2006-01-18 ES ES06707742T patent/ES2333814T3/es active Active
- 2006-01-18 DK DK06707742.0T patent/DK1848446T3/da active
- 2006-01-18 KR KR1020077020249A patent/KR20070107106A/ko not_active Application Discontinuation
- 2006-01-18 AU AU2006212322A patent/AU2006212322B2/en not_active Ceased
- 2006-01-18 CA CA2597154A patent/CA2597154C/en not_active Expired - Fee Related
- 2006-01-18 MX MX2007009588A patent/MX2007009588A/es active IP Right Grant
- 2006-01-18 WO PCT/EP2006/050276 patent/WO2006084782A1/de active Application Filing
- 2006-01-18 EP EP06707742A patent/EP1848446B1/de active Active
- 2006-01-18 RU RU2007133509/15A patent/RU2359680C2/ru not_active IP Right Cessation
- 2006-01-18 US US11/815,568 patent/US8722101B2/en not_active Expired - Fee Related
- 2006-01-18 DE DE502006005100T patent/DE502006005100D1/de active Active
- 2006-01-18 CN CNA2006800115263A patent/CN101155593A/zh active Pending
- 2006-01-18 BR BRPI0606974-6A patent/BRPI0606974A2/pt not_active IP Right Cessation
-
2007
- 2007-08-02 IL IL185020A patent/IL185020A/en not_active IP Right Cessation
- 2007-08-08 TN TNP2007000307A patent/TNSN07307A1/en unknown
- 2007-08-09 CR CR9300A patent/CR9300A/es unknown
- 2007-09-07 NO NO20074536A patent/NO20074536L/no not_active Application Discontinuation
- 2007-09-07 ZA ZA200707716A patent/ZA200707716B/xx unknown
-
2009
- 2009-12-14 CY CY20091101333T patent/CY1109685T1/el unknown
-
2010
- 2010-01-14 HR HR20100027T patent/HRP20100027T1/hr unknown
-
2014
- 2014-03-10 US US14/202,056 patent/US20140187514A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| KOLB Е. «Relation of iron supply and iron metabolism to infectious diseases and parasitoses and the competence of the immune system», Zeitschrift fur die Gesamte Innere Medizin., 01.11.1988, vol.43, N21, p.597-601, abstract Grantham-McGregor S., Ani С. «A review of studies on the effect of iron deficiency on cognitive development in children.», J. Nutrition, 02.2001, vol.131, N2S-2, p.649s-668s. * |
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20100027T1 (hr) | 2010-02-28 |
| ATE445406T1 (de) | 2009-10-15 |
| AU2006212322B2 (en) | 2012-01-19 |
| JP2008530049A (ja) | 2008-08-07 |
| CA2597154A1 (en) | 2006-08-17 |
| WO2006084782A1 (de) | 2006-08-17 |
| CA2597154C (en) | 2011-03-15 |
| UA88347C2 (ru) | 2009-10-12 |
| IL185020A (en) | 2013-10-31 |
| US20080214496A1 (en) | 2008-09-04 |
| US8722101B2 (en) | 2014-05-13 |
| MX2007009588A (es) | 2007-09-12 |
| DK1848446T3 (da) | 2010-02-15 |
| ZA200707716B (en) | 2008-06-25 |
| ES2333814T3 (es) | 2010-03-01 |
| EP1848446B1 (de) | 2009-10-14 |
| EP1848446A1 (de) | 2007-10-31 |
| US20140187514A1 (en) | 2014-07-03 |
| PT1848446E (pt) | 2009-12-21 |
| PL1848446T3 (pl) | 2010-03-31 |
| NO20074536L (no) | 2007-11-05 |
| BRPI0606974A2 (pt) | 2009-07-28 |
| KR20070107106A (ko) | 2007-11-06 |
| TNSN07307A1 (en) | 2008-12-31 |
| JP5060312B2 (ja) | 2012-10-31 |
| RU2007133509A (ru) | 2009-03-20 |
| AU2006212322A1 (en) | 2006-08-17 |
| CN101155593A (zh) | 2008-04-02 |
| CY1109685T1 (el) | 2014-08-13 |
| IL185020A0 (en) | 2007-12-03 |
| CR9300A (es) | 2007-12-07 |
| DE502006005100D1 (de) | 2009-11-26 |
| SI1848446T1 (sl) | 2010-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2359680C2 (ru) | Применение комплексных соединений железа (iii) | |
| RU2411037C2 (ru) | Применение комплексных соединений железа (iii) для производства лекарственного средства для перорального лечения железодефицитных состояний у больных, страдающих хроническими воспалительными заболеваниями кишечника | |
| Low et al. | Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005 | |
| US20140303067A1 (en) | Treatment of eosinophilic esophagitis | |
| Reshad | A study of cord blood albumin as a predictor of significant neonatal hyperbilirubinemia in term and preterm neonates | |
| Solomons et al. | The Cut‐Off Criterion for a Positive Hydrogen Breath Test in Children: A Reappraisal | |
| Moyo et al. | The pathophysiology of neonatal jaundice in urosepsis is complex with mixed bilirubin | |
| HARDWICK et al. | Near fatal fire ant envenomation of a newborn | |
| Gwillim et al. | Duloxetine-induced lymphocytic colitis | |
| Hamid | Clinical hematology | |
| RU2442980C2 (ru) | Способ диагностики пищевой аллергии у детей | |
| Khan et al. | The beneficial effects of breastfeeding on microvascular function in 11-to 14-year-old children | |
| Gupta et al. | Hypokalemic periodic paralysis: 2 novel causes | |
| Doe et al. | Jejunal pH and folic acid. | |
| Estambale et al. | Bancroftian filariasis in Kwale District of Kenya. III. Quantification of the IgE response in selected individuals from an endemic community | |
| Harms et al. | Food allergy in infancy and childhood | |
| Nwabuko et al. | Hepatic-related hematologic disorders in children | |
| Manuel et al. | Invasive meningococcal disease: Should the first episode prompt further investigation? | |
| Takara et al. | Oryza Ceramide® containing rice-derived glucosylceramides and a ceramide decreases cumulative days with cold symptoms in Japanese healthy subjects | |
| Chukwu | Pharmacodynamic Effects of Sulphadoxine-Pyrimethamine on Pregnancy Outcome in Women Attending Cntenatal clinic and Their Knowledge, Attitude and Practice of Intermittent Preventive Treatment | |
| Jabeen et al. | A CASE REPORT ON COMPLICATIONS OF WILSON’S DISEASE | |
| Pfirrman et al. | Environmental Interventions for Preventing Atopic Diseases | |
| Wainwright et al. | Management of haematological disorders | |
| Adam | The role of parenteral phenobarbitone in the treatment of neonatal hyperbilirubinaemia. | |
| Zafer et al. | Anemic crisis due to Mycoplasma pneumoniae complication in sickle cell patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160119 |